文献速递肺结节与肺癌

LRIG1 标记高增殖潜能气道基底细胞并限制肺鳞癌生长

Lrig1 expression identifies airway basal cells with high proliferative capacity and restricts lung squamous cell carcinoma growth.
PubMed 文献 · Eur Respir J · 2022-03-31

研究利用 Lrig1 敲入报告小鼠和支气管镜获取的人气道上皮细胞,发现 LRIG1 异质表达于气道基底细胞,并标记体外增殖与自我更新潜能更高的祖细胞亚群。在 NTCU 诱导的肺鳞癌小鼠模型中,Lrig1 功能缺失导致癌前病变早期异常高增殖和更大的侵袭性肿瘤,提示 LRIG1 调控肺鳞癌进展。

要点

  • LRIG1 异质表达于气道基底细胞,标记高增殖潜能祖细胞亚群。
  • Lrig1 功能缺失加速 NTCU 小鼠肺鳞癌癌前病变增殖和肿瘤进展。
  • LRIG1 下调与肺鳞癌患者生存下降相关,具临床相关性。

核心结论

  • LRIG1 是具高增殖潜能气道基底祖细胞的标志物,并调控肺鳞癌癌前病变进展。

研究设计与样本

  • 使用 Lrig1 敲入报告小鼠和支气管镜获取的人气道上皮细胞。
  • 采用 NTCU 诱导的小鼠肺鳞癌模型进行功能评估。

主要发现

  • LRIG1 在气道基底细胞中异质表达,标记体外增殖与自我更新潜能更高的祖细胞亚群。
  • Lrig1 功能缺失导致 NTCU 小鼠癌前病变早期异常高细胞增殖。
  • Lrig1 功能缺失导致形成显著更大的侵袭性肿瘤,提示疾病进展加速。
  • LRIG1 在癌前气道病变和侵袭性肺鳞癌中下调,与患者生存下降相关。

临床怎么用

  • LRIG1 可作为评估肺鳞癌癌前病变进展风险的候选生物标志物。
  • NTCU 诱导肺鳞癌模型可用于候选抑癌基因和癌基因的功能评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lung squamous cell carcinoma (LUSC) accounts for a significant proportion of cancer deaths worldwide, and is preceded by the appearance of progressively disorganised pre-invasive lesions in the airway epithelium. Yet the biological mechanisms underlying progression of pre-invasive lesions into invasive LUSC are not fully understood. LRIG1 (leucine-rich repeats and immunoglobulin-like domains 1) is downregulated in pre-invasive airway lesions and invasive LUSC tumours and this correlates with decreased lung cancer patient survival. METHODS AND RESULTS: Using an Lrig1 knock-in reporter mouse and human airway epithelial cells collected at bronchoscopy, we show that during homeostasis LRIG1 is heterogeneously expressed in the airway epithelium. In basal airway epithelial cells, the suspected cell of origin of LUSC, LRIG1 identifies a subpopulation of progenitor cells with higher in vitro proliferative and self-renewal potential in both the mouse and human. Using the N-nitroso-tris-chloroethylurea (NTCU)-induced murine model of LUSC, we find that Lrig1 loss-of-function leads to abnormally high cell proliferation during the earliest stages of pre-invasive disease and to the formation of significantly larger invasive tumours, suggesting accelerated disease progression. CONCLUSION: Together, our findings identify LRIG1 as a marker of basal airway progenitor cells with high proliferative potential and as a regulator of pre-invasive lung cancer progression. This work highlights the clinical relevance of LRIG1 and the potential of the NTCU-induced LUSC model for functional assessment of candidate tumour suppressors and oncogenes.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Succony L, Gómez-López S, Pennycuick A, et al. Lrig1 expression identifies airway basal cells with high proliferative capacity and restricts lung squamous cell carcinoma growth. Eur Respir J. 2022. PMID: 34385275. doi:10.1183/13993003.00816-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。